Cardiometabolic multiple long-term conditions
Disease1 paper2 findings
- Humans1
Associations
2Fasting plasma glucose
upin humans1OR 1.39
1 study
Fasting plasma glucose
upin humans1OR 1.39
Fasting plasma glucose raises the risk of cardiometabolic multiple long-term conditions in humans (OR 1.39; 95% CI, 1.18-1.64).
Humansper 1 mmol/L increase12-15 yearsn = 2,233
Glycemic Markers and Cardiometabolic Multiple Long-Term Conditions: Comparative Roles of Glycated Hemoglobin and Fasting Plasma Glucose in the English Longitudinal Study of Ageing · Mayo Clinic proceedings. Innovations, quality & outcomes · 12 Sep 2026
HbA1c
upin humans1OR 1.99
1 study
HbA1c
upin humans1OR 1.99
HbA1c raises the risk of cardiometabolic multiple long-term conditions in humans (OR 1.99; 95% CI, 1.51-2.63).
Humansper 1% increase12-15 yearsn = 2,233
Glycemic Markers and Cardiometabolic Multiple Long-Term Conditions: Comparative Roles of Glycated Hemoglobin and Fasting Plasma Glucose in the English Longitudinal Study of Ageing · Mayo Clinic proceedings. Innovations, quality & outcomes · 12 Sep 2026